Immunohistochemical study of correlation between histologic subtype and expression of epithelial-mesenchymal transition-related proteins in Synovial Sarcomas

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 8, 2011, Pages 1001-1009

  Subramaniam, Mani Manish ^a   Navarro, Samuel ^a   Liombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; FXYD5 PROTEIN, HUMAN; MEMBRANE PROTEIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; COMPARATIVE STUDY; CONNECTIVE TISSUE TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; TISSUE MICROARRAY;

CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; SARCOMA, SYNOVIAL; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80051962513     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/2010-0071-OAR1     Document Type: Article

References (47)

1. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/Akt pathways. Oncogene. 2005;24(50):7443-7454. (Pubitemid 41637984)
2. Moreno-Bueno C, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene. 2008;27(55):6958-6969.
3. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl. 1993;17:155-158. (Pubitemid 24041293)
4. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 1989;8(6):1711-1717. (Pubitemid 19273986)
5. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular B-catenin levels by the adenomatous polyposis coli (APC) tumorsuppressor protein. Proc Natl Acad Sci USA. 1995;92(7):3046-3050.
6. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science. 1996;272(5264):1023-1026. (Pubitemid 26259322)
7. Saito T, Oda Y, Kawaguchi K, et al. E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma. Oncogene. 2004;23(53):8629-8638. (Pubitemid 39576470)
8. Saito T, Oda Y, Sugimachi K, et al. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. Am J Pathol.2001;159(6):2117-2124. (Pubitemid 33104266)
9. Batlle E, Sancho E, Francf C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2(2):84-89.
10. Bolós V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci. 2003;116(3):499-511. (Pubitemid 36231290)
11. van Grunsven LA, Michiels C, Van de Putte T, et al. Interaction etween Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J Biol Chem. 2003; 278(28):26135-26145. (Pubitemid 36835383)
12. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927-939. (Pubitemid 38798858)
13. Rodrigo I, Cato AC, Cano A. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element. Exp Cell Res. 1999;248(2):358-371. (Pubitemid 29394796)
14. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3(3):155-166.
15. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 2000;275(47):36803-36810. (Pubitemid 32002090)
16. Yook JI, Li X Y, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. I Biol Chem. 2005;280(12):11740-11748. (Pubitemid 40418488)
17. Gavrilovic J, Moens G, Thiery JP, Jouanneau J. Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul. 1990;1(13):1003-1014.
18. Timmerman LA, Grego-Bessa J, Raya A, et al. Notch promotes epithelialmesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18(1):99-115. (Pubitemid 38090691)
19. Novak A, Hsu SC, Leung-Hagesteijn C, et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Set USA. 1998;95(8):4374-4379.
20. dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 2001;30(1):1-14.
21. Saito T, Oda Y, Sakamoto A, et al. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of Bcatenin mutations in synovial sarcoma. J. Pathol. 2000;192(3):342-350.
22. Laskin WB, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126(4):425-431. (Pubitemid 34286806)
23. Izumi T, Oda Y, Hasegawa T, et al. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol. 2007;31(1):85-94. (Pubitemid 46036906)
24. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann. Surg Oncol. 2005;12(6):488-496. (Pubitemid 40884264)
25. Sato H, Hasegawa T, Kanai Y, et al. Expression of cadherins and their undercoat proteins (α-, β-, and γ-catenins and p120) and accumulation of Bcatenin with no gene mutations in synovial sarcoma. Virchows Arch 2001; 438(1 ):23-30. (Pubitemid 32128186)
26. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995;14(24): 6107-6115. (Pubitemid 26007298)
27. Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999;79(4):459-465. (Pubitemid 29190435)
28. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2(2):76-83.
29. Saito T, Nagai M, Ladanyi M. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. Cancer Res 2006;66(14):6919-6927. (Pubitemid 44197666)
30. Poser I, Domfnguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem. 2001;276(27):24661-24666.
31. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses Ecadherin in breast cancer. Cancer Res 2002;62(6):1613-1618. (Pubitemid 34408479)
32. Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am J Pathol. 2002;161(5):1881-1891. (Pubitemid 35265545)
33. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA. 2002;99(1 ):365-370. (Pubitemid 34060368)
34. Aoki S, Shimamura T, Shibata T, et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer. 2003; 88(5):726-732. (Pubitemid 36411452)
35. Shimada Y, Yamasaki S, Hashimoto Y, et al. Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res. 2004;10(8): 2818-2823. (Pubitemid 38509161)
36. Nishizawa A, Nakanishi Y, Yoshimura K, et al. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. Cancer. 2005; 103(8): 1693-1700. (Pubitemid 40490031)
37. Izumi T, Oda Y, Hasegawa T, et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol. 2006;19(6): 820-831. (Pubitemid 43780452)
38. Saito T, Oda Y, Sakamoto A, et al. APC mutations in synovial sarcoma. J Pathol. 2002;196(4):445-449. (Pubitemid 34262857)
39. Iwao K, Nakamori S, Kameyama M, et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 1998,58(5): 1021-1026. (Pubitemid 28182473)
40. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Frequent mutation and nuclear localization of B-catenin in anaplastic thyroid carcinoma. Cancer Res. 1999;59(8):1811-1815. (Pubitemid 29186147)
41. Kondo Y, Kanai Y, Sakamoto M, et al. B-Catenin accumulation and mutation of exon 3 of the B-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res. 1999;90(12):1301-1309. (Pubitemid 30032067)
42. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad. Sci USA. 2001;98(20):10983-10985. (Pubitemid 32928669)
43. Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 2003;63(9):2172-2178. (Pubitemid 36538623)
44. Friedrichs N, Küchler J, Endl E, et al. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma. J Pathol. 20O8;216(4):428-439.
45. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int) Dev Biol. 2004;48(5-6):365-375. (Pubitemid 39360388)
46. Akhurst RJ, and Derynck R. TGF-B signaling in cancer-a double-edged sword. Trends Cell Biol. 2001;11(11):S44-S51.
47. Medici D, Hay ED, Olsen BR. Snail and Slug promote epithelialmesenchymal transition through B-catenin-T-cell factor-4-dependent expression of transforming growth factor-B3. Mol Biol Cell. 2008;19(11):4875-4887.